Riyadh – Sharikat Mubasher: Endocare, a Dubai-based company specializing in metabolic health, successfully closed a key financing round to fuel its expansion into Saudi Arabia and the United Arab Emirates.

According to a recent press release, this milestone marks a major step in Endocare’s mission to deliver personalized, science-backed obesity and metabolic care across the Middle East.

The investment was led by RbetaQ Holding, a Germany-based family office known for supporting innovative ventures in healthcare and technology. The funding will enable Endocare to scale its operations, particularly in cities like Dubai and Riyadh, where demand for targeted, sustainable weight management solutions is on the rise.

With a strong foundation in clinical expertise and a patient-first approach, Endocare aims to meet the growing regional need for effective metabolic health interventions. 

As part of its growth strategy, Endocare is investing in AI-powered solutions to streamline patient journeys and improve clinical outcomes. These efforts reflect a broader vision to redefine metabolic healthcare by merging cutting-edge technology with compassionate, personalized care.

With operations rooted in Dubai and new momentum from this funding round, Endocare is well-positioned to play a leading role in tackling the region’s growing health challenges, empowering individuals to live longer, healthier lives through innovative and accessible treatment pathways.